Clinical Trials · NCT04466345
Semaglutide for the Treatment of Cognitive Dysfunction in Major Depressive Disorder
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- University Health Network, Toronto
- Enrollment
- 72
- Start date
- Oct 2021
- Locations
- 1 site, Canada
- Primary endpoint
- Executive Function Composite Score